# RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors

> **NCT05122572** · PHASE1 · UNKNOWN · sponsor: **Wuxi People's Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** Oncolytic Virus Injection (RT-01）

## Key facts

- **NCT ID:** NCT05122572
- **Lead sponsor:** Wuxi People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2022-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05122572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05122572, "RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05122572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*